Neuropharmacological profile of aqueous extract of anaphe venata larva (notondotidae) in rats

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 8, Issue 3, 2011, Pages 260-266

  Bamitale, K D S ^a   Akanmu, M A ^a   Ukponmwan, Otas E ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Anaphe venata; Ataxia; Chewing. cholinergic; Dopaminergic; Rats; Stretching

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPHETAMINE; ANAPHE VENATA EXTRACT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; FLUMAZENIL; MUSCARINIC RECEPTOR; NALOXONE; NATURAL PRODUCT; OPIATE RECEPTOR; SCOPOLAMINE; THIAMINE; UNCLASSIFIED DRUG;

ANAPHE VENATA; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; LOCOMOTION; MALE; NEUROPHARMACOLOGY; NONHUMAN; RAT; REARING; SILKWORM; SNIFFING; STEREOTYPY; STRETCHING;

AMPHETAMINE; ANIMALS; ATAXIA; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; GROOMING; INJECTIONS, INTRAPERITONEAL; LARVA; LOCOMOTION; MOTHS; NALOXONE; NEUROPHARMACOLOGY; NEUROTRANSMITTER AGENTS; RATS; SCOPOLAMINE HYDROBROMIDE; STEREOTYPED BEHAVIOR; THIAMINE; WATER;

EID: 84856789136     PISSN: None     EISSN: 01896016     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adamolekun B. (1992). A seasonal ataxic syndrome in South Western Nigeria: An etiological hypothesis of acute thiamine deficiency. Ethnicity Dis 2:185-186.
2. Adamolekun B. (1993). Anaphe venata entomophagy and seasonal ataxic syndrome in Southwest Nigeria. Lancet 341:629.
3. Adamolekun B., Ibikunle F.R. (1994). Investigation of an epidemic of seasonal ataxia in Ikare, western Nigeria. Acta Neurol Scand 90(5):309-11.
4. Adamolekun B., Lawal T., Ndububa D.A., Balogun M.O. (1994). Serum albumin levels and intraethnic variations in susceptibility to seasonal ataxia in Nigerians. Ethnicity Dis 94: 87-90.
5. Ajayi A.A., Ukponmwan O.E. (1994). Possible evidence of angiotensin II and endogenous opoioid modulation of novelty-induced rearing in rats. Afr J Med Sci 22:287-290.
6. Akanmu M.A., Adeosun O.S., Ilesanmi O.R. (2007). Neuropharmarological effects of oleamide in male and female mice. Behav Brain Res 182: 88-94.
7. Andine P., Widermark N., Axelson R., Nyberg G., Olofsson U., Martensson E., Sandberg M. (1999). Characterization of MK-801-induced behavioras a putative rat model of psychosis. J Pharm Exp Ther. 290:1393-1408.
8. Ashiru M.O. (1988). The food value of the larvae of Anaphe venata Butler (Lepidoptera:Notodontidae). Ecology of Food and Nutrition. 28:227-242.
9. Ayoka A.O., Akomlafe R.O., Iwalewa E.O., Ukponmwan O.E. (2005). Studies on the anxiolytic effect of Spondias mombin L (Anarcardiaceae) extracts. Afr. J. Trad. CAM 2(2): 153-165.
10. Barclay L.L., Gibson G.E., Blass J.P. (1982). Cholinergic therapy of abnormal open-field behavior in thiamine-deficient rats. J Nutrition 112: 1906-1913.
11. Bentley C.J., Bourson A., Boess F.G., Kevin C.F.F., Marsden C.A., Petit N., Sleight A.J. (1999). Investigation of stretching behavior induced by the selective 5-HT6 receptor antagonist, Ro 04-6790 in rats. Br J Pharmacol 126: 1537-1542.
12. Brown RE, Corey S, Moore AK. (1999). Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav Genet 26:263-271.
13. Castellani S., Giannini A., Adams P.M. (1982). Effects of naloxone, metencephalin, and morphine on phencyclidineinduced behavior in the rat. Psychopharmacology (Berl) 78: 76-80.
14. Chapman C.A., Yeomans J.S., Blaha C.D., Blackburn J.R. (1997). Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neurosci 76:177-186.
15. Ciccia R.M, Langlais P.J. (2000). An examination of the synergistic interaction of ethanol and thiamine deficiency in the development of neurological signs and long-term cognitive and memory impairments Alchol Clin Exp Res 24(5): 622-634.
16. Eghashira N, Kurauchi K, Iwasaki K, Mishima K, Orito K, Oishi R and Fujiwara M. (2008). Schizandrin reverses memory impairment in rats. Phytother Res., 22: 49-52.
17. Ferrari W., Gessa G.L., Vargiu L. (1963). Behavioral effects induced by intracisternally injected ACTH and MSH. Ann NY Acad Sci 104:330-345.
18. Fuhrmann G., Durkin T., Thiriet G., Kempf E., Ebel A. (1985). Cholinergic neurotransmission in the central nervous system of the Snell Dwarf Mouse. J Neurosci Res 13: 417-430.
19. Gallate J.E., Saharov T., Mallet P.E., McGregor I.S. (1999). Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370(3):233-240.
20. Hurd Y.L., Herkenham M. (1992). Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 16:97-104.
21. Iwalewa E.O., Onayade O.A., Oyedapo O.O., Daniyan O.M. (2005). Sub-acute toxicity and biochemical effects of extracts of Anaphe venata larvae in mice. Afr J Biomed Res 8: 89-93.
22. McPhie A.A., Barr G.A. (2000). The role of opioid receptors in morphine withdrawal in the infant rat. Brain Res Dev Brain Res 124(1-2): 73-80.
23. Meador K.J., Nichols N.E., Franke P., Durkin M.W., Oberzan R.L., Moore E.E., Loring D.W. (1993). Evidence for a central cholinergic effect of high-dose thiamine. Ann Neurol., 34(5):724-726.
24. Nishimune T., Watanabe Y., Okazaki H., Akai H. (2000) Thiamin is decoposed due to Anaphe spp. Entomophagy in seasonal ataxia patients in Nigeria. J Nutr 130(6):1625-8.
25. Onayade O.A., Adamolekun B., Omobuwajo O.R. (2004). Behavioral effects and toxicity potentials of non-polar and polar extracts of Anaphe venata larvae in mice. Hamdard Medicus XLVII: 153-156.
26. Parker E.M., Cubeddu X.L. (1986). Effects of d-amphetamine and dopamine synthesis inhibitor on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J Pharm Exp Ther 237: 193-203.
27. Sadile A.G. (1995). Long-time habituation of theta-related activity components of albino rats in the Lat-maze. In: Sanberg PR, Ossenkopp KP and Kavaliers M (eds.). Motor Activity and Movement Disorders: Measurement and Analysis. Humana Press, New York. pp 1-54.
28. Siqueira I.R., Lara D.R., Silva D., Gaieski F.S., Nunes D.S., Elisabetsky E. (1998). Psychopharmacological properties of Ptochopetalum molacoides Bentham (Olacaceae). Pharmaceut Biol 36 (5): 327-334.
29. Sturgeon R.D., Fessler R.G., Metzer H.Y. (1979). Behavioral ratings for assessing phencyclidine-induced locomotor activity, stereotyped behaviors and ataxia. Eur J Pharmacol 59:169-179.
30. Tsai S., Huang Y.H., Chang L.S., Yang Y.C., Sim C.B. (1995). Alterations in local cerebral glucose utilization in rats after chronic amphetamine administration without subsequent challenge. Psychiatry Res 57(1):65-73.
31. Waldegrave W. (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the member states regarding the protection of animals used for eexperimental and other scientific purposes. Pp. 1-46.
32. Wang J.Q., McGinty J.F. (1996). D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22:114-122.
33. Wright J and Morley D.C. (1958) Encephalitis tremens. Lancet 1:871-873